Marchex Reports Q1 Financials, Details Archenia Acquisition & Telmetrics Settlement
MCHX sits 23% above its 52-week low of $1.322.
Summary
Marchex reported Q1 2026 financial results showing improved operating cash flow, while detailing the significant, potentially dilutive acquisition of Archenia and the final settlement of the Telmetrics litigation.
Key Events · Earnings and Guidance · MCHX
-
Improved Q1 Operating Cash Flow
Net cash used in operating activities significantly improved to $(0.514) million for Q1 2026, compared to $(2.622) million in Q1 2025, indicating better operational efficiency.
-
Archenia Acquisition Details Revealed
Marchex entered a definitive agreement on May 8, 2026, to acquire Archenia, Inc. for $10.0 million in 6% convertible promissory notes (convertible at $1.80/share) and up to 4.0 million additional Class B shares based on performance targets. This represents a potential dilution of approximately 21.57% if all convertible notes and earnout shares are issued.
-
Telmetrics Litigation Settlement Finalized
A $2.0 million settlement agreement for the Telmetrics civil action was finalized on April 14, 2026. Payments include $1.0 million by May 14, 2026 (including $0.25 million from escrow), $0.5 million by November 16, 2026, and $0.5 million by May 17, 2027. A $2.1 million accrual for this was recorded in Q4 2025.
-
Q1 2026 Financial Performance
The company reported Q1 2026 revenue of $10.618 million, a 7% decrease from Q1 2025. Net loss improved to $(1.724) million, or $(0.04) per share, compared to $(1.982) million, or $(0.05) per share, in Q1 2025.
Analysis · MCHX · Technology
This quarterly report provides full financial details for Q1 2026, confirming and elaborating on several significant events previously announced in 8-K filings. The company demonstrated improved operating cash flow, a critical positive for a small-cap firm. However, the detailed terms of the Archenia acquisition reveal substantial potential dilution from convertible notes and earnout shares, which could significantly impact existing shareholders. The finalization of the Telmetrics litigation settlement removes a prior uncertainty, with the financial impact largely accounted for in previous periods.
At the time of this filing, MCHX was trading at $1.62 on NASDAQ in the Technology sector, with a market capitalization of approximately $71.8M. The 52-week trading range was $1.32 to $2.31. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.